Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Neurostimulation Devices Market, by Devices
1.4.2 Europe Neurostimulation Devices Market, by Applications
1.4.3 Europe Neurostimulation Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, Oct – 2020, May) Leading Players
Chapter 4. Europe Neurostimulation Devices Market by Devices
4.1 Europe Spinal Cord Stimulators Market by Country
4.2 Europe Deep Brain Stimulators Market by Country
4.3 Europe Sacral Nerve Stimulators Market by Country
4.4 Europe Vagus Nerve Stimulators Market by Country
4.5 Europe Other Devices Market by Country
Chapter 5. Europe Neurostimulation Devices Market by Applications
5.1 Europe Pain Management Market by Country
5.2 Europe Hearing Loss Market by Country
5.3 Europe Urinary Incontinence Market by Country
5.4 Europe Parkinson's Disease Market by Country
5.5 Europe Epilepsy Market by Country
5.6 Europe Other Applications Market by Country
Chapter 6. Europe Neurostimulation Devices Market by Country
6.1 Germany Neurostimulation Devices Market
6.1.1 Germany Neurostimulation Devices Market by Devices
6.1.2 Germany Neurostimulation Devices Market by Applications
6.2 UK Neurostimulation Devices Market
6.2.1 UK Neurostimulation Devices Market by Devices
6.2.2 UK Neurostimulation Devices Market by Applications
6.3 France Neurostimulation Devices Market
6.3.1 France Neurostimulation Devices Market by Devices
6.3.2 France Neurostimulation Devices Market by Applications
6.4 Russia Neurostimulation Devices Market
6.4.1 Russia Neurostimulation Devices Market by Devices
6.4.2 Russia Neurostimulation Devices Market by Applications
6.5 Spain Neurostimulation Devices Market
6.5.1 Spain Neurostimulation Devices Market by Devices
6.5.2 Spain Neurostimulation Devices Market by Applications
6.6 Italy Neurostimulation Devices Market
6.6.1 Italy Neurostimulation Devices Market by Devices
6.6.2 Italy Neurostimulation Devices Market by Applications
6.7 Rest of Europe Neurostimulation Devices Market
6.7.1 Rest of Europe Neurostimulation Devices Market by Devices
6.7.2 Rest of Europe Neurostimulation Devices Market by Applications
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Approvals:
7.2 Boston Scientific Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.3 Nevro Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals:
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Acquisition and Mergers:
7.4.5.3 Product Launches and Product Expansions:
7.4.5.4 Approvals:
7.5 NeuroSigma, Inc.
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 Integer Holdings Corporation
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 LivaNova PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Approvals:
7.7.5.2 Acquisition and Mergers:
7.8 NeuroPace, Inc.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Approvals:
7.8.2.2 Product Launches and Product Expansions:
7.9 Neuronetics, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Partnerships, Collaborations, and Agreements:
7.9.5.2 Approvals:
7.1 Synapse BioMedical, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Approvals: